FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

37541011000001103: Lyrinel XL 5mg tablets (Mawdsley-Brooks & Company Ltd) 30 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 04-Sep 2019. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
365171000001117 Lyrinel XL 5mg tablets (Mawdsley-Brooks & Company Ltd) 30 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
365181000001115 Lyrinel XL 5mg tablets (Mawdsley-Brooks & Company Ltd) 30 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Lyrinel XL 5mg tablets (Mawdsley-Brooks & Company Ltd) 30 tablet Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Lyrinel XL 5mg tablets (Mawdsley-Brooks & Company Ltd) 30 tablet Is a Oxybutynin 5mg modified-release tablets 30 tablet true Inferred relationship Existential restriction modifier
Lyrinel XL 5mg tablets (Mawdsley-Brooks & Company Ltd) 30 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Lyrinel XL 5mg tablets (Mawdsley-Brooks & Company Ltd) 30 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Lyrinel XL 5mg tablets (Mawdsley-Brooks & Company Ltd) 30 tablet Has AMP Lyrinel XL 5mg tablets (Mawdsley-Brooks & Company Ltd) true Inferred relationship Existential restriction modifier
Lyrinel XL 5mg tablets (Mawdsley-Brooks & Company Ltd) 30 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Lyrinel XL 5mg tablets (Mawdsley-Brooks & Company Ltd) 30 tablet Has specific active ingredient Oxybutynin hydrochloride true Inferred relationship Existential restriction modifier
Lyrinel XL 5mg tablets (Mawdsley-Brooks & Company Ltd) 30 tablet Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Lyrinel XL 5mg tablets (Mawdsley-Brooks & Company Ltd) 30 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Lyrinel XL 5mg tablets (Mawdsley-Brooks & Company Ltd) 30 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Lyrinel XL 5mg tablets (Mawdsley-Brooks & Company Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Lyrinel XL 5mg tablets (Mawdsley-Brooks & Company Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel import true Inferred relationship Existential restriction modifier
Lyrinel XL 5mg tablets (Mawdsley-Brooks & Company Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Lyrinel XL 5mg tablets (Mawdsley-Brooks & Company Ltd) 30 tablet Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start